These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 22138074

  • 21. Strategy for effective brain drug delivery.
    Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M.
    Eur J Pharm Sci; 2010 Aug 11; 40(5):385-403. PubMed ID: 20497904
    [Abstract] [Full Text] [Related]

  • 22. Targeting the brain--surmounting or bypassing the blood-brain barrier.
    Potschka H.
    Handb Exp Pharmacol; 2010 Aug 11; (197):411-31. PubMed ID: 20217538
    [Abstract] [Full Text] [Related]

  • 23. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L, Rosch J, Putnam D.
    J Control Release; 2016 Oct 28; 240():251-266. PubMed ID: 26724368
    [Abstract] [Full Text] [Related]

  • 24. Prodrug strategy for enhanced therapy of central nervous system disease.
    Xia X, Zhou Y, Gao H.
    Chem Commun (Camb); 2021 Sep 06; 57(71):8842-8855. PubMed ID: 34486590
    [Abstract] [Full Text] [Related]

  • 25. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK.
    Neurodegener Dis; 2007 Sep 06; 4(4):287-91. PubMed ID: 17627131
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
    Perioli L, Ambrogi V, Bernardini C, Grandolini G, Ricci M, Giovagnoli S, Rossi C.
    Eur J Med Chem; 2004 Aug 06; 39(8):715-27. PubMed ID: 15276305
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Brain drug delivery systems.
    Jiang X.
    Pharm Res; 2013 Oct 06; 30(10):2427-8. PubMed ID: 23921487
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F, Loiola RA, Roig A, Rosell A, Culot M.
    Neurochem Int; 2021 Mar 06; 144():104952. PubMed ID: 33400964
    [Abstract] [Full Text] [Related]

  • 34. Delivery of therapeutic molecules into the CNS.
    Emborg ME, Kordower JH.
    Prog Brain Res; 2000 Mar 06; 128():323-32. PubMed ID: 11105691
    [No Abstract] [Full Text] [Related]

  • 35. Novel central nervous system drug delivery systems.
    Stockwell J, Abdi N, Lu X, Maheshwari O, Taghibiglou C.
    Chem Biol Drug Des; 2014 May 06; 83(5):507-20. PubMed ID: 24325540
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Polymeric nanoparticles - targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities.
    Rollerova E, Scsukova S, Jurcovicova J, Mlynarcikova A, Szabova E, Kovriznych J, Zeljenkova D.
    Endocr Regul; 2011 Jan 06; 45(1):49-60. PubMed ID: 21314211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.